| Robust immune responses elicited by a fully synthetic three-component vaccine S Ingale, MA Wolfert, J Gaekwad, T Buskas, GJ Boons Nature chemical biology 3 (10), 663-667, 2007 | 388 | 2007 |
| Glycopeptides as versatile tools for glycobiology T Buskas, S Ingale, GJ Boons Glycobiology 16 (8), 113R-136R, 2006 | 217 | 2006 |
| Glycopeptide-specific monoclonal antibodies suggest new roles for O-GlcNAc CF Teo, S Ingale, MA Wolfert, GA Elsayed, LG Nöt, JC Chatham, L Wells, ... Nature chemical biology 6 (5), 338-343, 2010 | 196 | 2010 |
| Towards a fully synthetic carbohydrate‐based anticancer vaccine: synthesis and immunological evaluation of a lipidated glycopeptide containing the tumor‐associated Tn antigen T Buskas, S Ingale, GJ Boons Angewandte Chemie 117 (37), 6139-6142, 2005 | 180 | 2005 |
| A Synthetic Lectin for O‐Linked β‐N‐Acetylglucosamine Y Ferrand, E Klein, NP Barwell, MP Crump, J Jiménez‐Barbero, C Vicent, ... Angewandte Chemie 121 (10), 1807-1811, 2009 | 148 | 2009 |
| Selecting improved peptidyl motifs for cytosolic delivery of disparate protein and nanoparticle materials K Boeneman, JB Delehanty, JB Blanco-Canosa, K Susumu, MH Stewart, ... Acs Nano 7 (5), 3778-3796, 2013 | 127 | 2013 |
| Increasing the antigenicity of synthetic tumor‐associated carbohydrate antigens by targeting toll‐like receptors S Ingale, MA Wolfert, T Buskas, GJ Boons ChemBioChem 10 (3), 455-463, 2009 | 124 | 2009 |
| On resin side-chain cyclization of complex peptides using CuAAC S Ingale, PE Dawson Organic letters 13 (11), 2822-2825, 2011 | 94 | 2011 |
| Synthesis of glyco (lipo) peptides by liposome-mediated native chemical ligation S Ingale, T Buskas, GJ Boons Organic letters 8 (25), 5785-5788, 2006 | 69 | 2006 |
| Detection of cell–cell interactions via photocatalytic cell tagging RC Oslund, T Reyes-Robles, CH White, JH Tomlinson, KA Crotty, ... Nature Chemical Biology 18 (8), 850-858, 2022 | 41 | 2022 |
| Glycolipopeptide antibodies GJ Boons US Patent 7,820,797, 2010 | 29 | 2010 |
| Synthesis and analysis of the membrane proximal external region epitopes of HIV‐1 S Ingale, JS Gach, MB Zwick, PE Dawson Journal of Peptide Science 16 (12), 716-722, 2010 | 25 | 2010 |
| A high throughput protein microarray approach to classify HIV monoclonal antibodies and variant antigens EY Dotsey, A Gorlani, S Ingale, CJ Achenbach, DN Forthal, PL Felgner, ... PLoS One 10 (5), e0125581, 2015 | 18 | 2015 |
| Liposome-mediated ligation S Ingale, T Buskas, GJ Boons US Patent 8,980,311, 2015 | 12 | 2015 |
| Glycopeptide and uses thereof GJ Boons, T Buskas, AJ Harvey, S Ingale, M Wolfert, RL Wells US Patent App. 13/002,180, 2012 | 11 | 2012 |
| Glycopeptide and uses thereof GJ Boons, T Buskas, S Ingale, M Wolfert US Patent 9,446,144, 2016 | 4 | 2016 |
| Glycopeptide and uses thereof GJ Boons, T Buskas, S Ingale, M Wolfert US Patent 9,211,345, 2015 | 4 | 2015 |
| Glycopeptide and uses thereof GJ Boons, T Buskas, S Ingale, M Wolfert US Patent 9,211,345, 2015 | 4 | 2015 |
| Glycopeptide and uses thereof GJ Boons, T Buskas, S Ingale, M Wolfert US Patent 9,211,345, 2015 | 4 | 2015 |
| Scandium (iii) Triflate as a Lewis Acid Catalyst of Oxime Ligation PA Cistrone, A Dirksen, S Ingale, PE Dawson Australian Journal of Chemistry 73 (4), 377-379, 2020 | 3 | 2020 |
